Apparatus for Treatment of Dermatological Conditions

Inactive Publication Date: 2008-02-28
SONOVIA HLDG
View PDF11 Cites 87 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0157]FIG. 7 shows the effect of Topical 1 formulation on HSP72 expression in the epidermis.
[0158]FIG. 8 shows the effect of Topical 1 formulation on fibrillin expression proximal to the dermal-epidermal junction following ultrasound treatment.
[0159]FIG. 9 shows the effect of Topical 1 formulatio

Problems solved by technology

However, the skin is not generally thought of as an efficient delivery route, due to the low permeability of the stratum corneum and the epidermis in general.
First, cavitation results from the rapidly oscillating pressure field, causing bubble formation and collapse, which mechanically creates channels through the stratum corneum.
(1 MHz, 2 W/cm2) have been shown to cause skin damage.
Cosmetic treatments that aim to improve skin quality are also hindered by the barrier function of the epidermis and in particular the outer stratum corneum.
Diffusion of substances of molecular weight around 500 Da and above is known to be inefficient.
The very low frequency long wave ultrasound disclosed, 10 to 40 kHz, is in the range generally recognised as being disruptive ultrasound, which may be damaging to cells, and thus for safety reasons this is not suitable for general use except at very low power levels.
Such symptoms include a thinning of both the epidermis and the dermis, a flattening of the j

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Apparatus for Treatment of Dermatological Conditions
  • Apparatus for Treatment of Dermatological Conditions
  • Apparatus for Treatment of Dermatological Conditions

Examples

Experimental program
Comparison scheme
Effect test

example 1

Topical Formulation “Topical 1”

[0162] Topical 1 is a composition according to the invention containing the following components:

TABLE 3ComponentAmount % w / wHyaluronic acid (0.8-3 MDa mol wt range)1%Hyaluronic acid (1.5-1.8 MDa mol wt range)3%Ethanol20%Ascorbic acid3%Trisodium ascorbyl phosphate (STAY C-50)1%Carnosine3%N-Acetyl Carnosine1%Arginine3%Sterile distilled waterto 100%

example 2

Patch Tests

[0163] The standard four-day patch test assay was extended to a seven-day period to examine the effect of the Topical 1 formulation under occlusion or delivered by ultrasound on the induction of fibrillin expression as a mechanism by which clinical signs of photoageing may be improved.

[0164] Subjects with clinical evidence of photoageing of forearm skin had the following products applied under occlusion to the dorsum of the forearm.

[0165] (1) 0.025% t-RA made up in a vehicle comprising 67.2% ethanol 30% propylene glycol and 0.05% butyl hydroxytoluene (preservative) to 100% with deionised water (positive control),

[0166] (2) Vehicle alone as above,

[0167] (3) Topical 1 formulation.

[0168] Topical 1 was delivered with and without use of an ultrasound device.

[0169] The positive control, topical application of 0.025% all-trans RA with occlusion was applied within the standard four-day time frame to minimise potentially deleterious side effects.

[0170] Fibrillin is a major...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

This invention relates to ultrasound delivery apparatus comprising flexible arrays of transducers and to methods and topical compositions for the treatment of skin, in particular for the treatment of cosmetic skin conditions and to improve the appearance of sun damaged and/or aged skin; the invention further relates to the use of such apparatus and compositions in methods of treating skin, which methods may incorporate the application of ultrasound. The composition may comprise one or more anti-gfycation agent, one or more anti-oxidant, a dermatologically acceptable excipient and optionally one or more substance capable of inducing expression of a molecular chaperone.

Description

TECHNICAL FIELD [0001] This invention relates to ultrasound delivery apparatus, methods and topical compositions for the treatment of skin, in particular for the treatment of cosmetic skin conditions and to improve the appearance of sun damaged and / or aged skin; the invention further relates to the use of such apparatus and compositions in methods of treating skin, which methods may incorporate the application of ultrasound. BACKGROUND OF THE INVENTION [0002] The skin is a potential route for delivery of pharmaceutical or cosmetically active agents to the body. However, the skin is not generally thought of as an efficient delivery route, due to the low permeability of the stratum corneum and the epidermis in general. Traditionally, topical application of pharmaceutical therapeutic agents has been targeted at localized dermatological sites. More recently, transdermal techniques have been used for systemic targeting especially as this route bypasses the hepatic circulation where degra...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61H1/00A61F13/00A61M35/00A61N7/00
CPCA61N7/00A61N2007/0078A61N2007/0073A61N2007/0008A61P17/00A61P3/04A61P43/00
Inventor LUEBCKE, PETER
Owner SONOVIA HLDG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products